SCHEMBL2186294

SCHEMBL2186294

Cc1ccc2c(O)cc(C(=O)O)cc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.54
P2RY14 Q15391 1/20 0.54
PRMT1 Q99873 1/20 0.47
CSNK2A1 P68400 1/20 0.47
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 2/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
MAPT P10636 2/20 0.45
CA4 P22748 2/20 0.45
CA6 P23280 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
LMNA P02545 2/20 0.45
TPMT P51580 1/20 0.45
TP53 P04637 1/20 0.45
CA3 P07451 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18961299 0.86 CYP2A6 (0.58) SLC6A2P2RY14CSNK2A1ALDH1A1SMN1; SMN2
SCHEMBL2184909 0.86 PRMT1 (0.59) SLC6A2P2RY14PRMT1CSNK2A1ALDH1A1
SCHEMBL27360806 0.85 SLC6A2 (0.59) SLC6A2P2RY14PRMT1ALDH1A1SMN1; SMN2
SCHEMBL13057644 0.84 TPMT (0.47) CSNK2A1ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL3420178 0.81 SLC6A2 (0.56) SLC6A2P2RY14PRMT1ALDH1A1SMN1; SMN2
SCHEMBL13057633 0.79 BCL2L1 (0.56) ALDH1A1SMN1; SMN2KDM4ECA12CA1
SCHEMBL4565723 0.79 CASP6 (0.54) SLC6A2P2RY14PRMT1ALDH1A1SMN1; SMN2
SCHEMBL12193501 0.79 SLC6A2 (0.54) SLC6A2P2RY14PRMT1ALDH1A1SMN1; SMN2
SCHEMBL7740699 0.78 TRPA1 (0.54) SLC6A2CSNK2A1ALDH1A1KDM4EMAPT
SCHEMBL30277939 0.78 TRPA1 (0.54) SLC6A2CSNK2A1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023287067-A1 ANTIBACTERIAL COMPOUND 주식회사 엘지화학 2023-01-19 WO disclosed
EP-2343279-B1 FUSED-RING DERIVATIVE AND MEDICAL APPLICATION OF SAME KISSEI PHARMACEUTICAL (JP) 2018-02-28 EP disclosed
US-9745336-B2 Fluorescent dye compounds, conjugates and uses thereof APPLIED BIOSYSTEMS, LLC (US) 2017-08-29 US disclosed
US-9745336-B2 Fluorescent dye compounds, conjugates and uses thereof APPLIED BIOSYSTEMS, LLC (US) 2017-08-29 US disclosed
US-20140303003-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof APPLIED BIOSYSTEMS, LLC (US) 2014-10-09 US disclosed
US-20140303003-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof APPLIED BIOSYSTEMS, LLC (US) 2014-10-09 US disclosed
US-8729267-B2 Fluorescent dye compounds, conjugates and uses thereof APPLIED BIOSYSTEMS, LLC (US) 2014-05-20 US disclosed
US-8729267-B2 Fluorescent dye compounds, conjugates and uses thereof APPLIED BIOSYSTEMS, LLC (US) 2014-05-20 US disclosed
CN-102186824-B Fused-ring derivative and medical application of same KISSEI PHARMACEUTICAL 2014-03-12 CN disclosed
US-8669266-B2 Quinoline-carboxamide derivatives as P2Y12 antagonists SANOFI (FR) 2014-03-11 US disclosed
EP-1265885-B1 HYDROXYLATED/CARBOXYLATED NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 2005-06-22 EP disclosed
EP-1248778-B1 SUBSTITUTED PHOTOCHROMIC 2H-NAPHTHO 1,2-B] PYRAN COMPOUNDS PPG IND OHIO INC (US) 2004-06-16 EP disclosed
US-6555028-B2 Polymeric matrix compatibilized naphthopyrans TRANSITIONS OPTICAL, INC. 2003-04-29 US disclosed
EP-1265885-A2 HYDROXYLATED/CARBOXYLATED NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 2002-12-18 EP disclosed
EP-1248778-A1 SUBSTITUTED PHOTOCHROMIC 2H-NAPHTHO 1,2-B] PYRAN COMPOUNDS PPG Industries Ohio Inc. (US) 2002-10-16 EP disclosed
US-6340766-B1 PHOTOCHROMIC DYES ON SUBSTRATES LIKE GLASS WITH PROTECTIVE COATINGS TRANSITION OPTICAL, INC. 2002-01-22 US disclosed
US-20020007078-A1 Novel substituted naphthopyrans TRANSITIONS OPTICAL LIMITED (IE) 2002-01-17 US disclosed
US-20010025948-A1 Polymeric matrix compatibilized naphthopyrans TRANSITIONS OPTICAL LIMITED (IE) 2001-10-04 US disclosed
WO-2001070719-A2 HYDROXYLATED/CARBOXYLATED NAPHTHOPYRANS TRANSITIONS OPTICAL, INC. (US) 2001-09-27 WO disclosed
WO-2001051483-A1 SUBSTITUTED PHOTOCHROMIC 2H-NAPHTHO [1,2-B] PYRAN COMPOUNDS PPG INDUSTRIES OHIO, INC. (US) 2001-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007078-A1 Novel substituted naphthopyrans CRYZ, NR2E3, UACA SLC6A2 3713/4885P2RY14 497/4885PRMT1 4310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.